These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30179010)

  • 1. Development of High-Functionality and -Quality Lipids with RGD Peptide Ligands: Application for PEGylated Liposomes and Analysis of Intratumoral Distribution in a Murine Colon Cancer Model.
    Suga T; Kato N; Hagimori M; Fuchigami Y; Kuroda N; Kodama Y; Sasaki H; Kawakami S
    Mol Pharm; 2018 Oct; 15(10):4481-4490. PubMed ID: 30179010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic Post-Insertion Method for the Efficient Preparation of PEGylated Liposomes Using High Functionality and Quality Lipids.
    Sugimoto Y; Suga T; Kato N; Umino M; Yamayoshi A; Mukai H; Kawakami S
    Int J Nanomedicine; 2022; 17():6675-6686. PubMed ID: 36597433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: Application of cyclic RGD peptide.
    Kato N; Sato T; Fuchigami Y; Suga T; Geng L; Tsurumaru M; Hagimori M; Mukai H; Kawakami S
    Eur J Pharm Sci; 2022 Sep; 176():106239. PubMed ID: 35714942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Evaluation of High Functionality and Quality Cell-penetrating Peptide Conjugated Lipid for Octaarginine Modified PEGylated Liposomes In U251 and U87 Glioma Cells.
    El-Gamal FR; Akl MA; Mowafy HA; Mukai H; Kawakami S; Afouna MI
    J Pharm Sci; 2022 Jun; 111(6):1719-1727. PubMed ID: 34863974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand peptide-grafted PEGylated liposomes using HER2 targeted peptide-lipid derivatives for targeted delivery in breast cancer cells: The effect of serine-glycine repeated peptides as a spacer.
    Suga T; Fuchigami Y; Hagimori M; Kawakami S
    Int J Pharm; 2017 Apr; 521(1-2):361-364. PubMed ID: 28237886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery.
    Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
    J Control Release; 2011 Jul; 153(2):141-8. PubMed ID: 21447361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.
    Rangger C; Helbok A; von Guggenberg E; Sosabowski J; Radolf T; Prassl R; Andreae F; Thurner GC; Haubner R; Decristoforo C
    Int J Nanomedicine; 2012; 7():5889-900. PubMed ID: 23226020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S; Sakurai Y; Harashima H
    Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic vessel-targeting DDS by liposomalized oligopeptides.
    Asai T; Oku N
    Methods Mol Biol; 2010; 605():335-47. PubMed ID: 20072892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas.
    Amin M; Badiee A; Jaafari MR
    Int J Pharm; 2013 Dec; 458(2):324-33. PubMed ID: 24148663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of high functionality and quality mannose-grafted lipids to produce macrophage-targeted liposomes.
    Hagimori M; Chinda Y; Suga T; Yamanami K; Kato N; Inamine T; Fuchigami Y; Kawakami S
    Eur J Pharm Sci; 2018 Oct; 123():153-161. PubMed ID: 30030100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.
    Chen CW; Lu DW; Yeh MK; Shiau CY; Chiang CH
    Int J Nanomedicine; 2011; 6():2567-80. PubMed ID: 22128247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an apolipoprotein E mimetic peptide-lipid conjugate for efficient brain delivery of liposomes.
    Kato N; Yamada S; Suzuki R; Iida Y; Matsumoto M; Fumoto S; Arima H; Mukai H; Kawakami S
    Drug Deliv; 2023 Dec; 30(1):2173333. PubMed ID: 36718920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging.
    Majzoub RN; Chan CL; Ewert KK; Silva BF; Liang KS; Jacovetty EL; Carragher B; Potter CS; Safinya CR
    Biomaterials; 2014 Jun; 35(18):4996-5005. PubMed ID: 24661552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
    Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
    Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of FA12 peptide-modified PEGylated liposomal doxorubicin (PLD) as an effective ligand to target Muc1 in mice bearing C26 colon carcinoma: in silico, in vitro, and in vivo study.
    Biabangard A; Asoodeh A; Jaafari MR; Mashreghi M
    Expert Opin Drug Deliv; 2022 Dec; 19(12):1710-1724. PubMed ID: 36373415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma.
    Nik ME; Malaekeh-Nikouei B; Amin M; Hatamipour M; Teymouri M; Sadeghnia HR; Iranshahi M; Jaafari MR
    Sci Rep; 2019 Jul; 9(1):9527. PubMed ID: 31267009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide.
    Zhang Q; Lu L; Zhang L; Shi K; Cun X; Yang Y; Liu Y; Gao H; He Q
    Sci Rep; 2016 Feb; 6():19800. PubMed ID: 26842655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.